According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$22.05 Million. In 2023 the company made an earning of -S$36.12 Million, an increase over its 2022 earnings that were of -S$51.27 Million. The earnings displayed on this page is the company's Pretax Income.